Haemonetics
261 hedge funds and large institutions have $3.87B invested in Haemonetics in 2018 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 83 increasing their positions, 101 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.68% less ownership
Funds ownership: 101.53% → 98.85% (-2.7%)
18% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 101
Holders
261
Holding in Top 10
6
Calls
$1.05M
Puts
–
Top Buyers
| 1 | +$81.9M | |
| 2 | +$63.7M | |
| 3 | +$49.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$37M |
Top Sellers
| 1 | -$69.7M | |
| 2 | -$67.3M | |
| 3 | -$56.5M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$49.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$46.2M |